Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I

Angulo, 2005, Myotoxic and cytolytic activities of dimeric Lys49 phospholipase A2 homologues are reduced, but not abolished, by a pH-induced dissociation, Toxicon, 46, 291, 10.1016/j.toxicon.2005.03.025 Arni, 1996, Phospholipase A2-a structural review, Toxicon, 34, 827, 10.1016/0041-0101(96)00036-0 Bahar, 2013, Antimicrobial peptides, Pharm. (Basel), 6, 1543, 10.3390/ph6121543 Barbosa, 2012, Design and synthesis of peptides from bacterial ParE toxin as inhibitors of topoisomerases, Eur. J. Med. Chem., 54, 591, 10.1016/j.ejmech.2012.06.008 Boman, 1993, Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine, Infect. Immun., 61, 2978, 10.1128/IAI.61.7.2978-2984.1993 Calvete, 2009, Venoms, venomics, antivenomics, FEBS Lett., 583, 1736, 10.1016/j.febslet.2009.03.029 Castro, 2006, Combinatorial synthesis and directed evolution applied to the production of alpha-helix forming antimicrobial peptides analogues, Curr. Protein Pept. Sci., 7, 473, 10.2174/138920306779025648 Castro, 2009, Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (“spotted treefrog”), Peptides, 30, 291, 10.1016/j.peptides.2008.11.003 Cespedes, 2012, Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus, Protein Pept. Lett., 19, 596, 10.2174/092986612800494011 Chatterjee, 1992, Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity, J. Antibiot. (Tokyo), 45, 839, 10.7164/antibiotics.45.839 Chioato, 2007, Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis, Biochim. Biophys. Acta, 1768, 1247, 10.1016/j.bbamem.2007.01.023 Chioato, 2002, Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2, Biochem. J., 366, 971, 10.1042/bj20020092 Chioato, 2003, Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis, Toxicon, 42, 869, 10.1016/j.toxicon.2003.11.027 CLSI, 2006 CLSI, 2008 Costa, 2008, Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells, Peptides, 29, 1645, 10.1016/j.peptides.2008.05.021 Cragg, 2013, Natural products: a continuing source of novel drug leads, Biochim. Biophys. Acta, 1830, 3670, 10.1016/j.bbagen.2013.02.008 Crusca, 2011, Influence of N-terminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide hylin-a1, Biopolymers, 96, 41, 10.1002/bip.21454 de Freitas Araújo, 2012, Correlation among antioxidant, antimicrobial, hemolytic, and antiproliferative properties of Leiothrix spiralis leaves extract, Int. J. Mol. Sci., 13, 9260, 10.3390/ijms13079260 de Freitas Araújo, 2013, Evaluation of syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis, Med. Mycol., 51, 673, 10.3109/13693786.2013.795294 de Lima, 2005, Snake venom: any clue for antibiotics and CAM?, Evid. Based Complement. Altern. Med., 2, 39, 10.1093/ecam/neh063 de Oliveira, 2001, A pH-induced dissociation of the dimeric form of a lysine 49-phospholipase A2 abolishes Ca2+-independent membrane damaging activity, Biochemistry, 40, 6912, 10.1021/bi0026728 Dennis, 1994, Diversity of group types, regulation, and function of phospholipase A2, J. Biol. Chem., 269, 13057, 10.1016/S0021-9258(17)36794-7 Dennis, 1991, Role of phospholipase in generating lipid second messengers in signal transduction, FASEB J., 5, 2068, 10.1096/fasebj.5.7.1901288 dos Santos, 2009, Comparative structural studies on Lys49-phospholipases A2 from Bothrops genus reveal their myotoxic site, J. Struct. Biol., 167, 106, 10.1016/j.jsb.2009.04.003 Falciani, 2007, Molecular basis of branched peptides resistance to enzyme proteolysis, Chem. Biol. Drug Des., 69, 216, 10.1111/j.1747-0285.2007.00487.x Fry, 2008, Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia), Mol. Cell. Proteomics, 7, 215, 10.1074/mcp.M700094-MCP200 Gebrim, 2009, Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region, Biologicals, 37, 222, 10.1016/j.biologicals.2009.01.010 Hancock, 2001, Cationic peptides: effectors in innate immunity and novel antimicrobials, Lancet Infect. Dis., 1, 156, 10.1016/S1473-3099(01)00092-5 Hancock, 1998, Cationic peptides: a new source of antibiotics, Trends Biotechnol., 16, 82, 10.1016/S0167-7799(97)01156-6 Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 Kaiser, 1970, Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides, Anal. Biochem., 34, 595, 10.1016/0003-2697(70)90146-6 Koduri, 2002, Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2, J. Biol. Chem., 277, 5849, 10.1074/jbc.M109699200 Kragol, 2001, The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding, Biochemistry, 40, 3016, 10.1021/bi002656a Kustanovich, 2002, Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives, J. Biol. Chem., 277, 16941, 10.1074/jbc.M111071200 Lee, 2008, Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide, Cancer Lett., 271, 47, 10.1016/j.canlet.2008.05.041 Liu, 2006, Induced endoplasmic reticulum (ER) stress and binding of over-expressed ER specific chaperone GRP78/BiP with dimerized epidermal growth factor receptor in mammalian cells exposed to low concentration of N-methyl-N′-nitro-N-nitrosoguanidine, Mutat. Res., 596, 12, 10.1016/j.mrfmmm.2005.10.015 Lomonte, 2010, Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from viperidae snake venoms: biomimetic activities and potential applications, Curr. Pharm. Des., 16, 3224, 10.2174/138161210793292456 Lomonte, 1999, Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro, Toxicon, 37, 145, 10.1016/S0041-0101(98)00171-8 Lomonte, 2003, Comparative study of synthetic peptides corresponding to region 115-129 in Lys49 myotoxic phospholipases A2 from snake venoms, Toxicon, 42, 307, 10.1016/S0041-0101(03)00149-1 Lomonte, 2009, The phospholipase A2 homologues of snake venoms: biological activities and their possible adaptive roles, Protein Pept. Lett., 16, 860, 10.2174/092986609788923356 Lomonte, 1994, Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling, J. Biol. Chem., 269, 29867, 10.1016/S0021-9258(18)43961-0 Lomonte, 2012, Snake venom Lys49 myotoxins: from phospholipases A2 to non-enzymatic membrane disruptors, Toxicon, 60, 520, 10.1016/j.toxicon.2012.02.007 Lorenzón, 2012, Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha, Antimicrob. Agents Chemother., 56, 3004, 10.1128/AAC.06262-11 Lorenzón, 2013, Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Cândida albicans cells, Amino Acids, 44, 1521, 10.1007/s00726-013-1475-3 Merrifield, 1963, Solid phase peptide synthesis. I. The synthesis of a tetrapeptide, J. Am. Chem. Soc., 2149, 10.1021/ja00897a025 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Murakami, 2002, Functional coupling between phospholipase A2S and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways, Adv. Exp. Med. Biol., 507, 15, 10.1007/978-1-4615-0193-0_3 Murillo, 2007, Fungicidal activity of a phospholipase-A2-derived synthetic peptide variant against Candida albicans, Rev. Esp. Quimioter., 20, 330 Murzyn, 2005, Phosphatidylethanolamine-phosphatidylglycerol bilayer as a model of the inner bacterial membrane, Biophys. J., 88, 1091, 10.1529/biophysj.104.048835 Núñez, 2001, Identification of the myotoxic site of the Lys49 phospholipase A2 from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities, Toxicon, 39, 1587, 10.1016/S0041-0101(01)00141-6 Páramo, 1998, Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom-synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region, Eur. J. Biochem., 253, 452, 10.1046/j.1432-1327.1998.2530452.x Patrzykat, 2002, Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrob. Agents Chemother., 46, 605, 10.1128/AAC.46.3.605-614.2002 Quan, 2009, UV resonance Raman spectroscopy probes the localization of tryptophan-containing antimicrobial peptides in lipid vesicles, J. Raman Spectrosc., 40, 260, 10.1002/jrs.2116 Renetseder, 1985, A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom, J. Biol. Chem., 260, 11627, 10.1016/S0021-9258(17)39077-4 Santamaría, 2005, Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region, Toxicon, 45, 807, 10.1016/j.toxicon.2004.09.012 Santos-Filho, 2014, Heterologous expression and biochemical and functional characterization of a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus snake, Biochimie, 93, 583, 10.1016/j.biochi.2010.11.016 Santos-Filho, 2008, A new acidic myotoxic, anti-platelet and prostaglandin I-2 inductor phospholipase A2 isolated from Bothrops moojeni snake venom, Toxicon, 52, 908, 10.1016/j.toxicon.2008.08.020 Schaloske, 2006, The phospholipase A2 superfamily and its group numbering system, Biochim. Biophys. Acta, 1761, 1246, 10.1016/j.bbalip.2006.07.011 Six, 2000, The expanding superfamily of phospholipase A2 enzymes: classification and characterization, Biochim. Biophys. Acta, 1488, 1, 10.1016/S1388-1981(00)00105-0 Soares, 2003, Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties, Toxicon, 42, 855, 10.1016/j.toxicon.2003.11.004 Soares, 2004, Alkylation of myotoxic phospholipases A2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production, Int. J. Biochem. Cell. Biol., 36, 258, 10.1016/S1357-2725(03)00237-1 Subbalakshmi, 1999, Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity, FEBS Lett., 448, 62, 10.1016/S0014-5793(99)00328-2 Travis, 2000, Bactericidal activity of mammalian cathelicidin-derived peptides, Infect. Immun., 68, 2748, 10.1128/IAI.68.5.2748-2755.2000 Trovatti, 2008, Peptides based on CcdB protein as novel inhibitors of bacterial topoisomerases, Bioorg. Med. Chem. Lett., 18, 6161, 10.1016/j.bmcl.2008.10.008 Tsai, 2007, Binding of a venom Lys-49 phospholipase A2 to LPS and suppression of its effects on mouse macrophages, Toxicon, 50, 914, 10.1016/j.toxicon.2007.06.025 Vicente, 2013, Dynamics and conformational studies of TOAC spin labeled analogues of Ctx(Ile(21))-Ha peptide from Hypsiboas albopunctatus, PLoS One, 8, e60818, 10.1371/journal.pone.0060818 Watanabe, 2003, Initiating structural studies of Lys49-PLA2 homologues complexed with an anionic detergent, a fatty acid and a natural lipid, Protein Pept. Lett., 10, 525, 10.2174/0929866033478726 Won, 2009, Interactions of antimicrobial peptide from C-terminus of myotoxin II with phospholipid mono- and bilayers, Biochim. Biophys. Acta, 1788, 2277, 10.1016/j.bbamem.2009.07.012 Yang, 2009, Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity, Biotechnol. Lett., 31, 233, 10.1007/s10529-008-9848-5 Zasloff, 2002, Innate immunity, antimicrobial peptides, and protection of the oral cavity, Lancet, 360, 1116, 10.1016/S0140-6736(02)11239-6